Omega‐3 polyunsaturated fatty acids (omega‐3 PUFAs), which are essential fatty acids that
humans should obtain from diet, have potential benefits for human health. In addition to …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome; its rising prevalence parallels the rise in obesity and diabetes. Historically …

Covering: 1958 to June 2018 Phenyl-γ-valerolactones (PVLs) and their related
phenylvaleric acids (PVAs) are the main metabolites of flavan-3-ols, the major class of …

Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, is a
multifactorial disease resulting from the interaction between environment, genetic …

Abstract n-3 polyunsaturated fatty acids (PUFA) have shown to exert beneficial effects in the
treatment of nonalcoholic fatty liver disease (NAFLD). Supplements of n-3 PUFA occur in …

Background & aims The prevention and treatment of non-alcoholic fatty liver disease
(NAFLD) has become one of the most urgent problems to be solved. To date, only a lifestyle …

The impact of sex and menopausal status in Alzheimer's disease remains understudied
despite increasing evidence of greater female risk, particularly in APOE4 carriers. Utilizing …

The intestinal microbiota plays an important role in host metabolism via production of dietary
metabolites. Microbiota imbalances are linked to type 2 diabetes (T2D), but dietary …

Refined foods are commonly depleted in certain bioactive components that are abundant in
'natural'(plant) foods. Identification and addition of these 'missing'bioactives in the diet is …

Metabolic-associated fatty liver disease (MAFLD), the main cause of chronic liver disease
worldwide, is a progressive disease ranging from fatty liver to steatohepatitis (metabolic …